Vanda Pharmaceuticals Inc. Earnings Per Share Diluted

• Vanda Pharmaceuticals Inc. showed a decrease of -1,033.3% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Vanda Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), Vanda Pharmaceuticals Inc.'s Earnings Per Share Diluted has declined by 181.2%.
• Historical annual values: Fiscal year 2025: $3.74 (loss) per share | Fiscal year 2024: $0.33 (loss) per share | Fiscal year 2023: $0.04 per share | Fiscal year 2022: $0.11 per share | Fiscal year 2021: $0.58 per share | Fiscal year 2020: $0.42 per share | Fiscal year 2019: $2.11 per share | Fiscal year 2018: $0.48 per share | Fiscal year 2017: $0.35 (loss) per share | Fiscal year 2016: $0.41 (loss) per share | Fiscal year 2015: $0.94 (loss) per share | Fiscal year 2014: $0.55 per share | Fiscal year 2013: $0.69 (loss) per share | Fiscal year 2012: $1.01 (loss) per share | Fiscal year 2011: $0.35 (loss) per share | Fiscal year 2010: $0.25 per share | Fiscal year 2009: $1.33 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026